Physician profile
Trung Le
NPI 1518072990
$348.92
in general payments reported to CMS, 2019-2025
9 companies · $21.46 in 2025
The $21.46 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.04 · 2020: $25.84 · 2021: $16.56 · 2022: $24.45 · 2023: $178 · 2024: $28.45 · 2025: $21.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $228.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $130.53 | 2023 | Hydrofera Blue |
| Aroa Biosurgery Incorporated | $50.08 | 2023-2024 | |
| Kerecis Limited | $29.72 | 2019 | |
| Organogenesis INC. | $25.96 | 2023 | Puraply |
| Musculoskeletal Transplant Foundation INC. | $25.84 | 2020 | |
| Medela LLC | $24.45 | 2022 | |
| Integra Lifesciences Corporation | $24.32 | 2019 | |
| Avita Medical Americas, LLC | $21.46 | 2025 | Cohealyx, Permeaderm, Recell |
| Convatec INC. | $16.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trung Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.